Literature DB >> 22375106

Deep brain stimulation for movement disorders - a history of success and challenges to conquer.

Lars Wojtecki1, Carlo Colosimo, Romulo Fuentes.   

Abstract

Entities:  

Year:  2012        PMID: 22375106      PMCID: PMC3284676          DOI: 10.3389/fnint.2012.00006

Source DB:  PubMed          Journal:  Front Integr Neurosci        ISSN: 1662-5145


× No keyword cloud information.
Up to date, tens of thousands patients have undergone implantation of deep brain stimulation electrodes – mainly for the treatment of Parkinson's disease, Essential Tremor, and Idiopathic Dystonia. Pizzolato and Mandat (2012) give a short and comprehensive review on the current status of deep brain stimulation for these movement disorders. For this special issue “The development of deep brain stimulation for neurological and psychiatric disorders: clinical, societal, and ethical issues” the reviews of Pizzolato and Mandat (2012) and of Sarem-Aslani and Mullett (2011) give an overview of the state of the art and currently approved indications for this therapy. There is no doubt, that especially in the field of movement disorders, deep brain stimulation is a history of great success in neurological therapy and a most valuable tool for research. However, especially in the light of other articles of this special issue that deal, e.g., with ethical issues, modulation of affect, cognition, and behavior, or possible changes of personality by deep brain stimulation, there remain some major challenges and questions for the future. We will have to conquer these challenges in order to understand and improve the technique – to finally transfer it to a successful therapy for other disorders especially in the neuro-psychiatric domain. These challenges are: To understand the natural history of the diseases and the underlying functional networks and circuits to select the best targets for neuromodulation. Beneficial motor effects of DBS are well described, e.g., there is class one evidence for the usefulness of DBS for Parkinson's disease (Deuschl et al., 2006; Weaver et al., 2009; Williams et al., 2010). However, to determine the real value in improving quality of life we have to gain more insight into the dynamics of the diseases. What is the right time point for implantation? Current data suggest that despite stable long terms effects on motor fluctuations in PD, we might miss the right time window in elderly patients as DBS will not manage to improve axial motor symptoms (Fasano et al., 2010b). On the other hand, prospective studies to examine the benefits of earlier implantation are still on the way. Furthermore, the interactions of disease state, operation, and implantation on cognitive side effects are not fully understood. Although there are many publications that show “on/off” effects on cognitive measurements, some data suggest that the implantation per se – and not the stimulation – might be the main cause of the decline in executive function (Okun et al., 2012). In line with this discussion we have to further study the right stimulation targets for to gain the best outcome. For example, GPI stimulation recognizes a renaissance, as it might be a cognitive safer target for some patients. In order to efficiently access and modulate the neural networks, many findings point into the direction that fiber tracts rather than nuclei might be the right target of choice – not only in PD, but also in thalamic stimulation for essential tremor: some findings suggest that differential stimulation of fiber tracts can be crucial for modulation of distinct symptoms like tremor versus ataxia (Fasano et al., 2010a). To disentangle the mechanisms of action of deep brain stimulation. The discussion about the effects of stimulating different fiber pathways leads to the point were we need a refined understanding of the connections and relationship between the different neural circuits involved in the desired output behavior. When it comes to STN stimulation, stimulation of afferents from cortical areas might be the main mechanism – as studies that used the optogenetic method suggest (Gradinaru et al., 2009). Additionally, volume of tissue activated studies, other functional imaging, microelectrode multi-site recordings, local field potential-, EEG-, and magnetoencephalographic studies, alone or combined, might provide guides to understand the stimulation effects on local and long range neuronal networks. To improve stimulation techniques On the basis of a better understanding of the mechanisms underlying DBS, we have to tailor new stimulation techniques. New programming options as interleaving (Wojtecki et al., 2011) and constant current devices (Okun et al., 2012) are on the market now. Furthermore, new electrodes with improved variability of stimulation direction will be helpful. Finally, as a result of disentangling the neuronal network codes (e.g., beta and high frequency oscillations in PD), closed-loop devices (Rouse et al., 2011), that could provide stimulation “on demand,” will hopefully be a major step forward to improve these therapies. To learn from the history of DBS in movement disorders. Especially when discussing modulation of complex behavior in patients with DBS and when we aim to increase the usage and indication of the technique, we have to learn from the lessons of the past. What was the reason for success of DBS in movement disorders? We think that there are four main points: determining the right patients with a distinct diagnosis for therapy, a detailed knowledge of the involved neural circuits, good designed and ethical clinical studies, and interdisciplinary cooperation between specialists (e.g., neurology, neurosurgery). On this basis, the future will be open for more indications and better understanding.
  11 in total

1.  Gait ataxia in essential tremor is differentially modulated by thalamic stimulation.

Authors:  Alfonso Fasano; Jan Herzog; Jan Raethjen; Franziska E M Rose; Muthuraman Muthuraman; Jens Volkmann; Daniela Falk; Rodger Elble; Günther Deuschl
Journal:  Brain       Date:  2010-10-05       Impact factor: 13.501

2.  Interleaving programming of subthalamic deep brain stimulation to reduce side effects with good motor outcome in a patient with Parkinson's disease.

Authors:  Lars Wojtecki; Jan Vesper; Alfons Schnitzler
Journal:  Parkinsonism Relat Disord       Date:  2011-01-07       Impact factor: 4.891

3.  A randomized trial of deep-brain stimulation for Parkinson's disease.

Authors:  Günther Deuschl; Carmen Schade-Brittinger; Paul Krack; Jens Volkmann; Helmut Schäfer; Kai Bötzel; Christine Daniels; Angela Deutschländer; Ulrich Dillmann; Wilhelm Eisner; Doreen Gruber; Wolfgang Hamel; Jan Herzog; Rüdiger Hilker; Stephan Klebe; Manja Kloss; Jan Koy; Martin Krause; Andreas Kupsch; Delia Lorenz; Stefan Lorenzl; H Maximilian Mehdorn; Jean Richard Moringlane; Wolfgang Oertel; Marcus O Pinsker; Heinz Reichmann; Alexander Reuss; Gerd-Helge Schneider; Alfons Schnitzler; Ulrich Steude; Volker Sturm; Lars Timmermann; Volker Tronnier; Thomas Trottenberg; Lars Wojtecki; Elisabeth Wolf; Werner Poewe; Jürgen Voges
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

4.  A chronic generalized bi-directional brain-machine interface.

Authors:  A G Rouse; S R Stanslaski; P Cong; R M Jensen; P Afshar; D Ullestad; R Gupta; G F Molnar; D W Moran; T J Denison
Journal:  J Neural Eng       Date:  2011-05-05       Impact factor: 5.379

5.  Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.

Authors:  Alfonso Fasano; Luigi M Romito; Antonio Daniele; Carla Piano; Massimiliano Zinno; Anna Rita Bentivoglio; Alberto Albanese
Journal:  Brain       Date:  2010-09       Impact factor: 13.501

6.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

7.  Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

Authors:  Frances M Weaver; Kenneth Follett; Matthew Stern; Kwan Hur; Crystal Harris; William J Marks; Johannes Rothlind; Oren Sagher; Domenic Reda; Claudia S Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff Bronstein; Gatana Stoner; Jill Heemskerk; Grant D Huang
Journal:  JAMA       Date:  2009-01-07       Impact factor: 56.272

8.  Industrial perspective on deep brain stimulation: history, current state, and future developments.

Authors:  Ali Sarem-Aslani; Keith Mullett
Journal:  Front Integr Neurosci       Date:  2011-09-27

9.  Deep brain stimulation for movement disorders.

Authors:  Gilberto Pizzolato; Tomasz Mandat
Journal:  Front Integr Neurosci       Date:  2012-01-25

10.  Optical deconstruction of parkinsonian neural circuitry.

Authors:  Viviana Gradinaru; Murtaza Mogri; Kimberly R Thompson; Jaimie M Henderson; Karl Deisseroth
Journal:  Science       Date:  2009-03-19       Impact factor: 47.728

View more
  1 in total

1.  Movement disorders and neuromodulation.

Authors:  Edward A Shipton
Journal:  Neurol Res Int       Date:  2012-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.